NCT00204776View on ClinicalTrials.gov

XELOX for Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2006

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Capecitabine and Oxaliplatin

Trial Locations (1)

53792

University of Wisconsin, Madison

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

University of Wisconsin, Madison

OTHER